SE0103650D0 - Therapeutic heterocyclic compounds - Google Patents
Therapeutic heterocyclic compoundsInfo
- Publication number
- SE0103650D0 SE0103650D0 SE0103650A SE0103650A SE0103650D0 SE 0103650 D0 SE0103650 D0 SE 0103650D0 SE 0103650 A SE0103650 A SE 0103650A SE 0103650 A SE0103650 A SE 0103650A SE 0103650 D0 SE0103650 D0 SE 0103650D0
- Authority
- SE
- Sweden
- Prior art keywords
- disorders
- compounds
- heterocyclic compounds
- useful
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (25)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103650A SE0103650D0 (sv) | 2001-11-01 | 2001-11-01 | Therapeutic heterocyclic compounds |
CNB028063929A CN100509794C (zh) | 2001-01-16 | 2002-01-15 | 治疗性杂环化合物 |
BR0206512-6A BR0206512A (pt) | 2001-01-16 | 2002-01-15 | Composto, método de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de um composto, e, processo para preparar um composto. |
MXPA03006250A MXPA03006250A (es) | 2001-01-16 | 2002-01-15 | Compuestos heterociclicos terapeuticos. |
US10/466,540 US20040082591A1 (en) | 2001-11-01 | 2002-01-15 | Therapeutic heterocyclic compounds |
PCT/SE2002/000068 WO2002055012A2 (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
IL15659502A IL156595A0 (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
CN 200610051523 CN1821236B (zh) | 2001-01-16 | 2002-01-15 | 治疗性杂环化合物 |
AU2002217742A AU2002217742B2 (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
NZ545374A NZ545374A (en) | 2001-01-16 | 2002-01-15 | Process for the production of therapeutic heterocyclic compounds |
EP02729622A EP1353913A2 (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
NZ526697A NZ526697A (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
KR1020087020183A KR20080079341A (ko) | 2001-01-16 | 2002-01-15 | 치료용 헤테로시클릭 화합물 |
JP2002555749A JP4280067B2 (ja) | 2001-01-16 | 2002-01-15 | 治療用ヘテロ環式化合物 |
KR1020037009432A KR100864356B1 (ko) | 2001-01-16 | 2002-01-15 | 치료용 헤테로시클릭 화합물 |
NZ535574A NZ535574A (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
CA002434152A CA2434152A1 (en) | 2001-01-16 | 2002-01-15 | Therapeutic heterocyclic compounds |
US10/051,776 US6812225B2 (en) | 2001-01-16 | 2002-01-16 | Therapeutic heterocyclic compounds |
ARP020100144A AR035733A1 (es) | 2001-01-16 | 2002-01-16 | Compuestos heterociclicos terapeuticos, uso de dichos compuestos para la preparacion de medicamentos, compuestos relacionados y procedimientos para preparar estos compuestos relacionados |
SA02220710A SA02220710B1 (ar) | 2001-01-16 | 2002-03-11 | مركبات حلقية غير متجانسة علاجية |
NO20033203A NO20033203L (no) | 2001-01-16 | 2003-07-15 | Terapeutiske heterocykliske forbindelser |
US10/889,350 US7045514B2 (en) | 2001-01-16 | 2004-07-12 | Therapeutic heterocyclic compounds |
US11/108,587 US7285662B2 (en) | 2001-01-16 | 2005-04-18 | Therapeutic heterocyclic compounds |
US11/864,102 US20080076759A1 (en) | 2001-01-16 | 2007-09-28 | Therapeutic Heterocyclic Compounds 507 |
ARP080103946A AR068413A2 (es) | 2001-01-16 | 2008-09-11 | Derivados 8-amino, metodos de preparacion, composiciones farmaceuticas y su uso en terapia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0103650A SE0103650D0 (sv) | 2001-11-01 | 2001-11-01 | Therapeutic heterocyclic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0103650D0 true SE0103650D0 (sv) | 2001-11-01 |
Family
ID=20285852
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0103650A SE0103650D0 (sv) | 2001-01-16 | 2001-11-01 | Therapeutic heterocyclic compounds |
Country Status (2)
Country | Link |
---|---|
US (1) | US20040082591A1 (sv) |
SE (1) | SE0103650D0 (sv) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
IT1254469B (it) * | 1992-02-25 | 1995-09-25 | Recordati Chem Pharm | Derivati benzopiranici e benzotiopiranici |
FR2760014B1 (fr) * | 1997-02-27 | 1999-04-09 | Adir | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
CA2199645C (en) * | 1997-03-11 | 1999-06-29 | Apotex Inc. | Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof |
FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2001
- 2001-11-01 SE SE0103650A patent/SE0103650D0/sv unknown
-
2002
- 2002-01-15 US US10/466,540 patent/US20040082591A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20040082591A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04004076A (es) | Compuestos terapeuticos de isoquinolina. | |
WO2002055012A3 (en) | Therapeutic heterocyclic compounds | |
SE0103649D0 (sv) | Therapeutic quinoline compounds | |
MXPA04004074A (es) | Compuestos de quinolona terapeuticos con propiedades antagonistas 5-ht. | |
WO2002055013A8 (en) | Therapeutic chromone compounds | |
DE50010931D1 (de) | Substituierte benzimidazole | |
HK1070896A1 (en) | Nicotinamide derivatives useful as p38 inhibitors | |
GB0209891D0 (en) | Novel compounds | |
DK0616807T3 (da) | Benzimidazol anvendelig i behandlingen af forstyrrelser i centralnervesystemet | |
ATE362473T1 (de) | 1,5-disubstituierte 3,4-dihydro-1h-4,5- döpyrimidin-2-on-verbindungen und ihre verwendung in der behandlung von durch csbp/p38 kinase beeinflussten krankheiten | |
SG147472A1 (en) | N-thiazol-2-yl-benzamide derivatives | |
WO2004098590A8 (en) | 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases | |
SE0103650D0 (sv) | Therapeutic heterocyclic compounds | |
SE0103647D0 (sv) | Therapeutic chromone compounds | |
DE60204882D1 (de) | Zykloalkenylsulfonamidderivate | |
DK1330451T3 (da) | Substituerede benzimidazol-2-oner som vasopressin receptor antagonister og neuropeptid Y modulatorer | |
EA200401099A1 (ru) | Производные гетероциклического амида | |
UY26416A1 (es) | Compuestos | |
PL1603877T3 (pl) | Nowe pochodne aminopirydyny jako antagoniści mGluR5 | |
GB0219639D0 (en) | Novel piperidin-2,6-dione salts and their use for the treatment of stress-related affective disorders | |
NO20050146D0 (no) | N,N-disubstituerte diazocykloalkaner nyttige i behandling av CNS-forstyrrelser grunnet serotonergisk dysfunksjon | |
MY136138A (en) | Hexacyclic compounds | |
MXPA05008464A (es) | Derivados de bencilurea y benciltiourea utiles como antagonistas del receptor de androgeno. | |
TH65445A (th) | สารประกอบเฮเทอโรไซคลิคที่สามารถใช้รักษาโรค | |
TW200510280A (en) | Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile |